Table A2.
360 U | 240 U | Placebo | p Value | |
---|---|---|---|---|
Week 0 total muscles injected | 392 | 386 | 345 | |
Flexor digitorum superficialis | 51 (92.7%) | 45 (86.5%) | 45 (93.8%) | 0.411 |
Flexor carpi radialis | 52 (94.5%) | 48 (92.3%) | 40 (83.3%) | 0.152 |
Flexor carpi ulnaris | 49 (89.1%) | 49 (94.2%) | 40 (83.3%) | 0.220 |
Biceps | 48 (87.3%) | 48 (92.3%) | 41 (85.4%) | 0.543 |
Flexor digitorum profundus | 37 (67.3%) | 37 (71.2%) | 34 (70.8%) | 0.905 |
Week 12 total muscles injected | 361 | 329 | 329 | |
Flexor digitorum superficialis | 48 (96.0%) | 39 (84.8%) | 42 (95.5%) | 0.100 |
Biceps | 46 (92.0%) | 40 (87.0%) | 36 (81.8%) | 0.354 |
Flexor carpi radialis | 43 (86.0%) | 42 (91.3%) | 37 (84.1%) | 0.598 |
Flexor carpi ulnaris | 43 (86.0%) | 43 (93.5%) | 35 (79.5%) | 0.155 |
Flexor digitorum profundus | 37 (74.0%) | 30 (65.2%) | 35 (79.5%) | 0.315 |